전기생리학 시장 - 세계 및 지역별 분석 : 제품별, 적응증별, 최종사용자별, 지역별 - 분석과 예측(2024-2034년)
Electrophysiology Market - A Global and Regional Analysis: Focus on Product, Indication, End User, and Region - Analysis and Forecast, 2024-2034
상품코드:1671815
리서치사:BIS Research
발행일:2025년 03월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
전 세계 전기생리학 시장 규모는 2024년 97억 7,000만 달러에서 2034년에는 327억 9,000만 달러에 달할 것으로 예상되며, 예측 기간인 2024년부터 2034년까지 연평균 12.88%의 CAGR을 기록할 것으로 예상됩니다.
이러한 확대의 주요 요인으로는 심혈관질환, 특히 부정맥의 유병률 증가, 3D 매핑 시스템, 카테터 절제 시스템, 진단 도구 등 전기생리학적 기기의 기술 발전을 들 수 있습니다.
또한, 전 세계 인구의 고령화, 특히 심장 질환의 위험이 높은 노인 인구의 증가는 전기생리학적 치료에 대한 수요 확대에 기여하고 있습니다. 카테터를 이용한 절제술과 같은 최소침습적 수술은 낮은 위험과 빠른 회복으로 인기를 끌며 시장을 더욱 견인하고 있습니다.
주요 시장 통계
예측 기간
2024-2034년
2024년 평가
97억 7,000만 달러
2034년 예측
327억 9,000만 달러
CAGR
12.88%
의료 인프라의 개선, 심장 건강에 대한 인식의 증가, 정부와 민간 부문의 투자로 인해 이 시장은 크게 성장할 것으로 보입니다.
세계 전기생리학 시장은 절제 카테터, 진단용 카테터, 검사 장비, 접근 장비, 기타 필수 도구 등의 제품을 포함한 여러 주요 부문으로 구성되어 있습니다. 이러한 제품들은 부정맥 및 심장 질환의 진단, 치료 및 관리에 필수적입니다. 시장 성장을 주도하는 주요 적응증으로는 심방세동, 심방조동, 방실 결절 재입구 빈맥(AVNRT), 울프-퍼킨슨-화이트 증후군, 기타 부정맥 등이 있으며, 효과적인 치료를 위해서는 고도의 전기생리학적 처치가 필요합니다.
전 세계적으로 이러한 질환의 유병률이 증가하고, 최소침습적 치료에 대한 수요와 전기생리학적 장치의 기술 혁신이 결합되어 시장이 크게 확대되고 있습니다. 카테터 기반 절제 시스템 및 고급 매핑 기술과 같은 고급 진단 및 치료 도구의 채택은 특히 다양한 지역에서 의료 접근성이 개선됨에 따라 이러한 성장을 더욱 가속화시키고 있습니다.
세계의 전기생리학 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 적응증별, 최종사용자별, 지역별 동향, 시장 진입 기업 프로파일 등의 정보를 전해드립니다.
목차
주요 요약
제1장 시장 : 업계 전망
업계 전망
동향 : 현재 및 향후의 영향 평가
특허 분석
규제 프레임워크
시장 역학 개요
제2장 세계의 전기생리학 시장(제품별), 100만 달러, 2022-2034년
실험장치
절제 카테터
액세스 디바이스
진단용 카테터
기타 제품
제3장 세계의 전기생리학 시장(적응증별), 100만 달러, 2022-2034년
심방세동(AF)
심방조동
방실결절 회귀성 빈맥(AVNRT)
볼프-파킨슨-화이트 증후군(WPW)
기타
제4장 세계의 전기생리학 시장(최종사용자별), 100만 달러, 2022-2034년
병원과 심장 센터
외래 수술 센터(ASC)와 전문 클리닉
제5장 세계의 전기생리학 시장(지역별), 100만 달러, 2022-2034년
지역별 개요
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
제6장 시장 - 경쟁 벤치마킹과 기업 개요
세계의 전기생리학 시장 : 경쟁 구도
기업 개요
Johnson & Johnson
Abbott Laboratories
Medtronic plc
Koninklijke Philips N.V.
GE HealthCare
Boston Scientific Corporation
Japan Lifeline Co., Ltd.
Stereotaxis, Inc.
MicroPort Scientific Corporation
Siemens Healthineers AG
Volta Medical
BioSig Technologies Inc.
CathVision ApS
Biotronik
Imricor Medical Systems, Inc.
제7장 조사 방법
ksm
영문 목차
영문목차
Introduction to Electrophysiology Market
The global electrophysiology market is projected to reach $32.79 billion by 2034 from $9.77 billion in 2024, growing at a CAGR of 12.88% during the forecast period 2024-2034. Key factors fueling this expansion include the rising prevalence of cardiovascular diseases, particularly arrhythmias, as well as technological advancements in electrophysiology devices such as 3D mapping systems, catheter ablation systems, and diagnostic tools.
Additionally, the aging global population, particularly the increase in elderly individuals at higher risk for heart conditions, is contributing to the growing demand for electrophysiology treatments. Minimally invasive procedures, such as catheter-based ablation, are gaining popularity due to their lower risks and quicker recovery times, further driving the market.
KEY MARKET STATISTICS
Forecast Period
2024 - 2034
2024 Evaluation
$9.77 Billion
2034 Forecast
$32.79 Billion
CAGR
12.88%
With improvements in healthcare infrastructure, rising awareness of heart health, and investments from both government and private sectors, the market is poised for substantial growth.
Market Introduction
The global electrophysiology market comprises several key segments, including products such as ablation catheters, diagnostic catheters, laboratory devices, access devices, and other essential tools. These products are crucial for the diagnosis, treatment, and management of arrhythmias and heart conditions. Major indications driving market growth include atrial fibrillation, atrial flutter, atrioventricular nodal re-entry tachycardia (AVNRT), Wolff-Parkinson-White syndrome, and other arrhythmias, all of which require advanced electrophysiology procedures for effective treatment.
As the prevalence of these conditions rises globally, coupled with the demand for minimally invasive treatments and technological innovations in electrophysiology devices, the market is witnessing significant expansion. The adoption of sophisticated diagnostic and therapeutic tools, including catheter-based ablation systems and advanced mapping technologies, is further accelerating this growth, especially as healthcare access improves across various regions.
Impact Analysis:
The electrophysiology market has made an impact in the following ways:
Improved Patient Outcomes:
Enhanced treatment precision and higher success rates due to advanced mapping and robotic-assisted procedures
Faster recovery times with minimally invasive procedures, leading to reduced complications
Reduction in Healthcare Costs:
Lower hospitalization costs due to minimally invasive procedures and shorter hospital stays
Long-term savings from reduced recurrence of heart conditions and fewer repeat procedures
Increased Access to Treatments:
Expanded healthcare access in emerging markets such as India, China, and Southeast Asia
Growth in medical tourism for electrophysiology services, offering affordable treatments globally
Personalized Treatment Approaches:
Tailored therapies enabled by advanced diagnostic and mapping technologies
More effective, targeted ablation procedures, thereby reducing damage to healthy heart tissues
Improved Quality of Life:
Better management of chronic arrhythmias, leading to reduced symptoms and hospitalizations
Reduced risk of stroke, particularly for atrial fibrillation patients, improving long-term health
Technological Advancements and Innovation:
Continued innovations in ablation catheters, mapping systems, and robotic-assisted devices
Integration of AI and machine learning to improve diagnostic accuracy and treatment planning
Growing Awareness and Early Diagnosis:
Increased public awareness, leading to earlier diagnoses and more timely interventions
Atrial Fibrillation (AF) Segment to Continue Dominating the Electrophysiology Market (by Indication)
Based on indication, the electrophysiology market is led by atrial fibrillation (AF), which held a 41.00% share in 2022.
Segmentation 3: by End User
Hospitals and Cardiac Centers
Ambulatory Surgery Centers (ASCs) and Specialty Clinics
Hospitals and Cardiac Centers Segment to Continue Holding its Dominance in the Electrophysiology Market (by End User)
Based on end user, the electrophysiology market is led by hospitals and cardiac centers, which held an 89.00% share in 2022.
Segmentation 4: by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest-of-Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest-of-Asia-Pacific
Latin America
Brazil
Mexico
Rest-of-Latin America
Middle East and Africa
China dominated the Asia-Pacific electrophysiology market in 2022, driven by several key factors. The country's large and aging population has significantly increased the prevalence of cardiovascular diseases, particularly arrhythmias, creating a high demand for electrophysiology services.
Additionally, government healthcare initiatives, such as increased investment in healthcare infrastructure and expanded access to medical insurance, have made advanced treatments more accessible. Technological advancements, including the adoption of cutting-edge devices such as 3D mapping systems and ablation catheters, have further fueled market growth.
China's rapidly growing healthcare sector, along with the rise in medical tourism and the presence of major global electrophysiology device manufacturers, has reinforced its position as the market leader in the region. Furthermore, the increasing focus on preventive healthcare has driven earlier diagnoses and interventions, further contributing to the market's expansion.
Recent Developments in the Electrophysiology Market
In November 2024, Johnson & Johnson announced the U.S. Food & Drug Administration (FDA) had approved its VARIPULSE Platform for the treatment of drug-refractory paroxysmal atrial fibrillation (AFib). This milestone reinforces the company's commitment to advancing innovative therapies that meet critical patient needs and drive market leadership in cardiovascular care.
In July 2024, BioSig Technologies signed a letter of intent to acquire Neuro-Kinesis Corp.'s novel EP catheter (Huygens) and robotic arm platform (Proteus) via stock transaction. The proposed acquisition (pending due diligence and shareholder vote) would bring advanced robotic catheter navigation technology into BioSig's portfolio.
In June 2024, Imricor commenced the VISABL-AFL IDE clinical trial (for U.S. FDA approval of Imricor's Vision-MR 2.0 ablation system) with the first two atrial flutter ablation cases performed at the Cardiovascular Institute of South Paris. This marked a significant step toward validating real-time iCMR ablation in a multi-center setting.
In January 2024, Boston Scientific Corporation announced that it had secured U.S. Food and Drug Administration (FDA) approval for its FARAPULSE Pulsed Field Ablation (PFA) System. This regulatory milestone underscores the company's commitment to pioneering advanced therapeutic solutions in cardiac care and reinforces its position as a leader in innovation.
Demand - Drivers and Limitations
Market Demand Drivers:
Innovative Technological Developments: Innovations such as pulsed-field ablation (PFA), high-density mapping, and integrated imaging solutions are revolutionizing electrophysiology (EP) procedures, enhancing precision, reducing procedure times, and improving patient safety. However, despite their clinical advantages, market adoption can be slow due to the conservative nature of the industry and the strong presence of legacy systems.
To accelerate adoption and maximize the impact of these advancements, companies must prioritize:
Strategic partnerships to integrate technologies within established workflows
Robust clinical validation to demonstrate long-term efficacy and safety
Proliferation of New Entrants and Its Market Implications: The influx of new entrants into the electrophysiology market presents both opportunities and challenges. On the one hand, these newcomers are fostering innovation by introducing cutting-edge technologies and disruptive business models. This dynamic encourages established players to intensify their research and development initiatives, ultimately improving clinical outcomes. The heightened competition also has the potential to enhance patient care and drive cost efficiencies over time.
Market Restraints:
Increasing Disease Incidence and Procedural Volume: The increasing prevalence of conditions such as atrial fibrillation (AF) and the growing volume of electrophysiology (EP) procedures serve as major growth drivers for the electrophysiology sector. These trends reinforce the clinical demand for advanced electrophysiology technologies while generating recurring revenue streams for device manufacturers. The expansion of procedural volumes supports further investments in electrophysiology lab infrastructure and incentivizes continuous innovation in mapping, ablation, and diagnostic technologies.
Increasing Device Reuse and Reprocessing Trends: The increasing trend toward device reuse and reprocessing in the electrophysiology market is emerging as a cost-containment and sustainability strategy. On one hand, this approach offers healthcare providers a means to reduce capital expenditures and extend the lifecycle of expensive devices, thereby improving overall resource efficiency. On the other hand, it introduces challenges such as ensuring strict regulatory compliance, maintaining rigorous quality control, and safeguarding device performance to ensure patient safety. While device reuse and reprocessing can deliver significant cost savings and environmental benefits, successful implementation will require a careful balance between economic efficiency and the uncompromised efficacy of clinical outcomes.
Market Opportunities:
Expansion of Emerging Markets: Emerging markets offer a compelling growth opportunity for the electrophysiology sector. Regions such as Asia-Pacific, Latin America, and the Middle East and Africa, characterized by lower device penetration and a growing cardiovascular disease burden, are investing in improved healthcare infrastructure. This evolving landscape enables companies to expand distribution networks, develop cost-effective products, and implement robust local physician training, ultimately driving long-term market growth despite regional challenges.
How can this report add value to an organization?
Product/Innovation Strategy: The global electrophysiology market has been extensively segmented based on various categories, such as product, indication, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.
Growth/Marketing Strategy: The partnership, alliance, and business expansion accounted for the maximum number of key developments in the global electrophysiology market between January 2022 and December 2024.
Competitive Strategy: The global electrophysiology market has numerous established players with product and service portfolios. Key players in the global electrophysiology market analyzed and profiled in the study involve established players offering electrophysiology products and services.
Methodology
Key Considerations and Assumptions in Market Engineering and Validation
Detailed secondary research was performed to ensure maximum coverage of manufacturers/suppliers operational in a country.
Exact revenue information, up to a certain extent, was extracted for each company from secondary sources and databases. The revenues specific to the product, indication, end user, and region were then estimated for each market player based on fact-based proxy indicators as well as primary inputs.
The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of electrophysiology.
The market contribution of the electrophysiology anticipated to be launched in the future has been calculated based on historical analysis. This analysis has been supported by proxy factors such as the innovation scale of the companies, the status of funding, collaborations, customer base, and patent scenario.
The scope of availability of electrophysiology products and services in a particular region has been assessed based on a comprehensive analysis of companies' prospects, regional end-user perception, and other factors impacting the launch of electrophysiology products and services in that region.
The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2020-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2034.
Revenues of the companies have been referenced from their annual reports for FY2020-FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, product approval status, market collaborations, and operational history.
Regional distribution of the market revenue has been estimated based on the companies in each region and the adoption rate of electrophysiology. All the numbers have been adjusted to a single digit after the decimal for better presentation in the report. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. The CAGR has been calculated for the period 2024-2034.
The market has been mapped based on the available electrophysiology. All the key companies with significant offerings in this field have been considered and profiled in this report.
Market strategies and developments of key players have been considered for the calculation of the potential of the market in the forecast period.
Primary Research:
The primary sources involve industry experts in the electrophysiology market, including the market players offering electrophysiology solutions. Resources such as CXOs, vice presidents, product managers, directors, territory managers, and business development have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.
The key data points taken from the primary sources include:
Validation and triangulation of all the numbers and graphs
Validation of the report's segmentation and key qualitative findings for electrophysiology
Understanding the competitive landscape and business model
Current and proposed production values of a product by market players
Validation of the numbers of the different segments of the market in focus
Percentage split of individual markets for regional analysis
Secondary Research
Open Sources
European Medicines Agency (EMA), American Chemical Society (ACS), Frontiers, World Health Organization (WHO), and National Center for Biotechnology Information (NCBI), among others
Annual reports, SEC filings, and investor presentations of the leading market players
Company websites and detailed study of their portfolios
Gold standard magazines, journals, whitepapers, press releases, and news articles
Databases
The key data points taken from the secondary sources include:
Segmentation and percentage share estimates
Company and country understanding and data for market value estimation
Key industry/market trends
Developments among top players
Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
Quantitative data for mathematical and statistical calculations
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.
Some prominent names in the global electrophysiology market include:
Abbott Laboratories
Johnson & Johnson
Medtronic plc
Boston Scientific Corporation
Japan Lifeline Co., Ltd.
Stereotaxis, Inc.
Siemens Healthineers AG
GE HealthCare
Koninklijke Philips N.V.
BioSig Technologies, Inc.
Table of Contents
Executive Summary
Scope and Definition
1 Market: Industry Outlook
1.1 Industry Outlook
1.1.1 Supply Chain Overview
1.1.1.1 Risks within the Supply Chain
1.1.2 Reimbursement Scenario
1.1.2.1 Overview
1.1.2.2 U.S.
1.1.2.3 Europe
1.1.2.4 Asia-Pacific
1.1.3 Value Chain Analysis
1.1.3.1 Overview
1.1.3.2 Stakeholders at Each Stage of the Value Chain
1.1.3.3 Strategic Partnerships, Mergers, and Acquisitions in the Value Chain
1.2 Trends: Current and Future Impact Assessment
1.2.1 Increasing Adoption of Advanced 3D Mapping Systems and Real-Time Imaging
1.2.2 Emerging Use of Artificial Intelligence in Predictive Modelling and Personalized Treatment
1.3 Patent Analysis
1.3.1 Patent Filing Trend (by Country, Year)
1.4 Regulatory Framework
1.4.1 U.S.
1.4.2 Canada
1.4.3 European Union (EU)
1.4.4 U.K.
1.4.5 France
1.4.6 Germany
1.4.7 Italy
1.4.8 Spain
1.4.9 Japan
1.4.10 China
1.4.11 India
1.4.12 South Korea
1.4.13 Australia
1.4.14 Brazil
1.4.15 Mexico
1.5 Market Dynamics Overview
1.5.1 Market Drivers
1.5.1.1 Innovative Technological Developments
1.5.1.2 Proliferation of New Entrants and Its Market Implications
1.5.1.3 Expanding Investments, Funding, and Grant Support for Cardiac Surgery and Electrophysiology
1.5.1.4 Increasing Disease Incidence and Procedural Volume
1.5.2 Market Restraints
1.5.2.1 High Product Costs and Inadequate Reimbursement Policies
1.5.2.2 Increasing Device Reuse and Reprocessing Trends
1.5.3 Market Opportunities
1.5.3.1 Expansion of Emerging Markets
1.5.3.2 Next-Generation Ablation Technologies
2 Global Electrophysiology Market (by Product), $Million, 2022-2034
2.1 Laboratory Devices
2.2 Ablation Catheters
2.3 Access Devices
2.4 Diagnostic Catheters
2.5 Other Products
3 Global Electrophysiology Market (by Indication), $Million, 2022-2034
